Take part in the highly important LSD Collaborative survey which closes soon
Updated: Aug 26
In this short clip Dr Tom Kenny, CEO of Rare Disease Research Partners (RDRP) urges you to take part in the highly important LSD Collaborative survey which closes soon. Every survey completed will improve treatments, services and care for everyone affected by a rare disease. Please take 20 minutes to complete the survey now before it closes on Friday 28 August.
*MPS Commercial is a Private Limited Company Registered No 08621283. MPS Commercial trades as Rare Disease Research Partners and is a wholly-owned, not-for-profit subsidiary of the Society for Mucopolysaccharide Diseases (the MPS Society), Registered Charity in England and Wales No. 1143472. Rare Disease Research Partners social objectives are to reinvest any surplus to support the mission of the MPS Society to transform the lives of patients through specialist knowledge, support, advocacy and research.